Fampyra Europska Unija - hrvatski - EMA (European Medicines Agency)

fampyra

biogen netherlands b.v.  - fampridine - multipla skleroza - ostali lijekovi protiv živčanog sustava - fampyra je indicirana za poboljšanje hodanja kod odraslih bolesnika s multiplom sklerozom s invaliditetom u šetnju (proširena skala statusa onesposobljenosti 4-7).

Zeposia Europska Unija - hrvatski - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

Fampridine Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

fampridine accord

accord healthcare s.l.u. - fampridine - multipla skleroza - ostali lijekovi protiv živčanog sustava - fampridine accord is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (edss 4-7).

Fampridin Teva 10 mg tablete s produljenim oslobađanjem Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

fampridin teva 10 mg tablete s produljenim oslobađanjem

teva gmbh, graf-arco-str. 3, ulm, njemačka - fampridin - tableta s produljenim oslobađanjem - urbroj: jedna tableta s produljenim oslobađanjem sadrži 10 mg fampridina

Vumerity Europska Unija - hrvatski - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).

Dimethyl fumarate Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Europska Unija - hrvatski - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetil fumarat - multipla skleroza, Рецидивно-Ремиттирующее - imunosupresivi - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimtruzic 120 mg tvrde želučanootporne kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dimtruzic 120 mg tvrde želučanootporne kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - dimetilfumarat - Želučanootporna kapsula, tvrda - urbroj: jedna tvrda želučanootporna kapsula sadrži 120 mg dimetilfumarata

Dimtruzic 240 mg tvrde želučanootporne kapsule Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

dimtruzic 240 mg tvrde želučanootporne kapsule

sandoz d.o.o., maksimirska 120, zagreb, hrvatska - dimetilfumarat - Želučanootporna kapsula, tvrda - urbroj: jedna tvrda želučanootporna kapsula sadrži 240 mg dimetilfumarata